Skip to content

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors With High Iatrogenic Risk

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05495529
Enrollment
61
Registered
2022-08-10
Start date
2013-01-01
Completion date
2022-05-11
Last updated
2022-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ablation Techniques, Carcinoma, Hepatocellular (RENI), Liver Neoplasm, Microwaves, Neoplasm Metastasis, Radiofrequency Ablation, Radiology, Interventional

Brief summary

This study aims to analyse retrospectively the feasibility, the safety, and the efficiency, of biliary or digestive protection with room air interposition for thermal ablation of central liver tumors with high iatrogenic risk. Thermal ablation is a mini-invasive and curative treatement of liver tumors. However, it requires to be carefull about surrunding organs, such as digestive structures or central biliary tree, which can be injured if not insulated. The technique of gas interposition to protect adjacent gut is already known and validated with carbonic gas. Nevertheless, resorption of this gas is very fast, making its use tricky to keep a correct insulation during the whole thermal ablation process. Room air interposition is easy to use and can offer a slow resorption speed. Furthermore no datas are available concerning the use of room air whatever the organ protected, and the protection of central biliary tree whatever the gas used.

Interventions

PROCEDUREThermal Ablation

Data collection about complications, succes of the procedure, succes of complete treatement, recurrence, biologic pertubations.

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

: * Patients with single malignant primary or secondary liver tumor * Thermal ablation area located within 1 centimeter from central biliary tree or gut * Thermal insulation using room air interposition * Follow-up of at least 2 months

Design outcomes

Primary

MeasureTime frameDescription
Feasability1 dayTechnical succes of the procedure = feasibility of insulation with room air
Security2 monthsComplications (intraoperative clinical or radiological event/abnormality, biological perturbation, clinical event in hospitalization report, imaging request), classified according to SIR (Society of Interventional Radiology) classification in two classes: minor (no additional therapy needed) and major (specific therapy needed) complications.
Efficacity2 monthsResponse in imaging (MRI or CT) for the tumor treated with thermal ablation
Clinical success2 monthsOverall survival

Secondary

MeasureTime frameDescription
Local and distant recurrence2 months1. Local recurrence: defined by MRI or CT recurrence within 10 mm from thermal ablation area 2. Distant recurrence: I. Hepatic: defined by MRI or CT intra-hepatic recurrence which is not defined as local recurrence II. Extrahepatic: defined by MRI or CT extra-hepatic recurrence
Local tumorous recurrence free survival2 monthsLocal tumorous recurrence free survival analysis
Progression free survival2 monthsLocal or distant recurrence free survival analysis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026